| Allison Vogel, PA-C | |
|
2412 N Oak St, Valdosta, GA 31602-2567 | |
| (229) 244-1400 | |
| (229) 244-5512 |
| Full Name | Allison Vogel |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 10 Years |
| Location | 2412 N Oak St, Valdosta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588068803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 2014036734 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Georgia Medical Center | Valdosta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valdosta Family Medicine Associates, P.c. | 5991791683 | 29 |
News Archive
University HealthSystem Consortium today announced that after a competitive bid process, it has awarded dual 3-year agreements for clinical/diagnostic equipment maintenance services to Universal Hospital Services, Inc. and Crothall Services Group. Contracts were effective January 1, 2010 and February 1, 2010 respectively.
A study conducted by researchers at the University of California, Los Angeles, suggests that smoking increases the risk of more severe lung disease in cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Researchers at National Jewish Health have discovered a cause of the dry, inflamed and itchy skin that plagues eczema patients.
MagForce Nanotechnologies AG, the Berlin-based medical technology company majority owned by Nanostart AG, today announced the successful completion of final trials demonstrating the efficacy of its Nano-Cancer® therapy in patients with recurrent glioblastoma, a frequent form of brain tumor which is highly malignant. The actual study results significantly exceeded the study objective.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allison Vogel, PA-C 2412 N Oak St, Valdosta, GA 31602-2567 Ph: (229) 244-1400 | Allison Vogel, PA-C 2412 N Oak St, Valdosta, GA 31602-2567 Ph: (229) 244-1400 |
News Archive
University HealthSystem Consortium today announced that after a competitive bid process, it has awarded dual 3-year agreements for clinical/diagnostic equipment maintenance services to Universal Hospital Services, Inc. and Crothall Services Group. Contracts were effective January 1, 2010 and February 1, 2010 respectively.
A study conducted by researchers at the University of California, Los Angeles, suggests that smoking increases the risk of more severe lung disease in cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Researchers at National Jewish Health have discovered a cause of the dry, inflamed and itchy skin that plagues eczema patients.
MagForce Nanotechnologies AG, the Berlin-based medical technology company majority owned by Nanostart AG, today announced the successful completion of final trials demonstrating the efficacy of its Nano-Cancer® therapy in patients with recurrent glioblastoma, a frequent form of brain tumor which is highly malignant. The actual study results significantly exceeded the study objective.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
› Verified 2 days ago
Chaeli Wisenbaker, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2412 N Oak St, Valdosta, GA 31602 Phone: 229-244-1400 Fax: 229-244-5512 | |
Ashly Mcdaniel, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3527 N Valdosta Rd, Valdosta, GA 31602 Phone: 229-247-2290 | |
Mr. Lonas Edward Lewis Ii, P.A.-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 3251 Inner Perimeter Rd Ste B, Valdosta, GA 31602 Phone: 229-259-0006 Fax: 229-259-0803 | |
Dana Woods Simpson, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 201 Woodrow Wilson Dr, Valdosta, GA 31602 Phone: 229-241-0041 Fax: 229-241-0048 | |
Matthew Allan Thomas, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2412 N Oak St, Valdosta, GA 31602 Phone: 229-244-1400 Fax: 229-244-5512 | |
Ms. Shonta K Winbush, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 704 Gil Harbin Ind Blvd, Valdosta, GA 31602 Phone: 229-242-9003 Fax: 229-242-0490 | |
Lela Faircloth Allen, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3018 N Patterson St, Valdosta, GA 31602 Phone: 229-433-7200 Fax: 229-249-4031 |